Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
293.23
282.57
385.86
405.79
358.83
242.55
187.54
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
293.23
282.57
385.86
405.79
358.83
242.55
187.54
Raw Material Cost
119.22
106.74
146.51
174.64
139.55
118.59
85.78
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
144.11
0.00
0.00
205.78
199.83
112.04
89.38
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.24
0.16
0.30
0.42
0.33
0.47
0.52
Selling and Distribution Expenses
125.67
167.17
177.37
189.87
144.53
69.26
59.50
Other Expenses
-11.11
2.50
4.37
-16.55
-17.07
-9.22
-6.73
Total Expenditure (Excl Depreciation)
278.14
299.10
367.91
405.23
313.50
208.17
167.87
Operating Profit (PBDIT) excl Other Income
15.1
-16.5
17.9
0.6
45.300000000000004
34.4
19.7
Other Income
1.08
18.80
37.61
11.95
6.80
1.26
1.14
Operating Profit (PBDIT)
22.08
10.23
69.14
25.34
63.06
44.61
28.55
Interest
0.24
0.16
0.30
0.42
0.33
0.47
0.52
Exceptional Items
5.43
25.38
7.19
-127.16
-229.75
1.12
0.54
Gross Profit (PBDT)
174.01
175.83
239.35
231.15
219.27
123.97
101.76
Depreciation
6.10
7.80
9.23
9.74
10.22
7.98
7.35
Profit Before Tax
21.17
27.64
66.80
-111.98
-177.24
37.28
21.23
Tax
1.72
0.57
5.98
4.17
4.79
4.79
1.93
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.45
27.07
60.82
-116.15
-182.02
32.49
19.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.45
27.07
60.82
-116.15
-182.02
32.49
19.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.45
27.07
60.82
-116.15
-182.02
32.49
19.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,315.46
1,244.80
1,233.54
-159.73
-82.22
233.23
75.98
Earnings per share (EPS)
0.04
0.05
0.09
-0.19
-0.3
0.05
0.03
Diluted Earnings per share
0.04
0.05
0.09
-0.19
-0.3
0.05
0.03
Operating Profit Margin (Excl OI)
5.08%
-5.79%
5.78%
0.9%
12.83%
14.58%
10.7%
Gross Profit Margin
9.3%
12.54%
19.7%
-25.19%
-46.55%
18.66%
15.24%
PAT Margin
6.63%
9.58%
15.76%
-28.62%
-50.73%
13.4%
10.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 3.75% vs -26.77% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -28.04% vs -55.43% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 344.19% vs -127.30% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 0.00% vs -33.33% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of MedSci Healthcare Holdings Ltd. With
Figures in Million
Consolidate Annual Results
Change(HKD)
Change(%)
Net Sales
293.23
1,760.37
-1,467.14
-83.34%
Other Operating Income
0.00
0.00
0.00
Total Operating income
293.23
1,760.37
-1,467.14
-83.34%
Raw Material Cost
119.22
919.78
-800.56
-87.04%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
144.11
418.88
-274.77
-65.60%
Power Cost
0
0
0.00
Manufacturing Expenses
0.24
15.56
-15.32
-98.46%
Selling and Distribution Expenses
125.67
1,509.54
-1,383.87
-91.67%
Other Expenses
-11.11
-38.35
27.24
71.03%
Total Expenditure (Excl Depreciation)
278.14
2,480.24
-2,202.10
-88.79%
Operating Profit (PBDIT) excl Other Income
15.08
-719.87
734.95
102.09%
Other Income
1.08
2.11
-1.03
-48.82%
Operating Profit (PBDIT)
22.08
-640.87
662.95
103.45%
Interest
0.24
15.56
-15.32
-98.46%
Exceptional Items
5.43
-317.43
322.86
101.71%
Gross Profit (PBDT)
174.01
840.59
-666.58
-79.30%
Depreciation
6.10
76.89
-70.79
-92.07%
Profit Before Tax
21.17
-1,050.75
1,071.92
102.01%
Tax
1.72
-0.39
2.11
541.03%
Provisions and contingencies
0
0
0.00
Profit After Tax
19.45
-1,002.26
1,021.71
101.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
19.45
-1,002.26
1,021.71
101.94%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-48.09
48.09
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.45
-1,050.35
1,069.80
101.85%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,315.46
610.98
704.48
115.30%
Earnings per share (EPS)
0.04
-1.64
1.68
102.44%
Diluted Earnings per share
0.04
-1.64
1.68
102.44%
Operating Profit Margin (Excl OI)
5.08%
-40.89%
0.00
45.97%
Gross Profit Margin
9.30%
-55.32%
0.00
64.62%
PAT Margin
6.63%
-56.93%
0.00
63.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 29.32 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 3.75% vs -26.77% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 1.95 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -28.04% vs -55.43% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.10 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 344.19% vs -127.30% in Dec 2024
Annual - Interest
Interest 0.02 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.00% vs -33.33% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.08%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






